Youngevity Services | Make money while saving people money

Welcome passionate purists, mindful go-getters and glass half-full types. You are in good company here, whether you are looking to build your own successful business; discover new services or savings on services you are already using; or just live a better more balanced life.

RYL Beta500 (Beta 1, 3-D Glucan)

RYL Beta500 (Beta 1,3-D Glucan) Low cost, high value immune support. These 500mg capsules provide the dose THAT research has shown to be the most effective when the immune response requires significantly MORE support. Provides multiple benefits to improve immune cell function. 60 capsules. *Patent Protected

Glucogenix - 60 Tablets

From Youngevity's ProLine , comes an advanced nutritional supplement that helps the body break down glucose and promote healthy blood sugar levels. The unique combination of botanicals, minerals and antioxidants found in Glucogenix , helps the body break

       Get Dr. Wallach's Books

       ⬇️      ⬇️       ⬇️       ⬇️

The Youngevity Opportunity

Youngevity provides powerful products that restore health and build vitality, in addition to having a powerful business opportunity that transforms lives.

Youngevity

Youngevity provides powerful products that restore health and build vitality, in addition to having a powerful business opportunity that transforms lives.

About Us

Youngevity provides powerful products that restore health and build vitality, in addition to having a powerful business opportunity that transforms lives.

Healthy Body Paks - Health & Nutrition

Youngevity provides powerful products that restore health and build vitality, in addition to having a powerful business opportunity that transforms lives.

Youngevity Store

YGY ID# 100961563 

Join Portal

Youngevity provides powerful products that restore health and build vitality, in addition to having a powerful business opportunity that transforms lives.

Shop Youngevity
Dead Doctors Don't Lie Radio Show

By now you have probably seen John Oliver’s comic take on the pharmaceutical industry’s influence on doctors’ prescribing habits. Media outlets from Mother Jones to the Wall Street Journal commented admiringly, and even the American Medical Association felt compelled to declare they were “committed to transparency” around drug company payments to doctors.

But satire will do very little to focus on the real problem if we’re distracted by the humor inherent in self-important doctors being bought off by a steak. What’s not funny is that America is the most medicated nation on earth, with some 70 percent of Americans taking prescription drugs—yet we have worse health outcomes than other industrialized countries. Part of the problem may be the drugs themselves. As Slate’s devastating expose on the fraud in clinical drug trials shows us: We don’t know much about the drugs we prescribe.

But as physicians, we have very little good information to go on. Even our most prestigious journals publish research based on falsified studies, according to Charles Seife, a journalism professor whose class spent a semester trying to figure out why the data don’t get corrected once research fraud comes to light.  “As a result,” Seife writes, “nobody ever finds out which data is bogus, which experiments are tainted, and which drugs might be on the market under false pretenses.”

If no one knows which data is bogus, we obviously have a big problem in conventional medicine.  Perhaps we shouldn’t be so focused on marketing shenanigans, and more concerned about the original study data before something becomes standard of care. Standard of care, of course, is driven by “research” that is incorporated into academic guidelines and is the basis of customer demand.

Understanding consumer demand takes very little study—just turn on the TV. Every year pharmaceutical companies spend over $3 billion on direct-to-consumer ads. These ads work: a patient who requests a specific drug will get it most of the time. (We are, by the way, the only country besides New Zealand that allows this.) But the question of how something becomes part of a recommended guideline is less obvious—and has a lot to do with pharmaceutical money paid to academic physicians in research and consulting fees.

Many of these physicians “leaders” then get to influence prescribing practices—since researchers and consultants are, well, experts. Consider the 2004 Cholesterol guidelines that resulted in an explosion in the use of statin drugs—eight out of nine of the doctors who wrote those guidelines were in receipt of money from statin manufacturers. The Harvard psychiatrist credited with hyping the use of stimulant drugs for ADHD—that has resulted in nearly 15 percent of our youth being medicated—received $1.6 million from producers of stimulant drugs. Prestigious medical journals—the ones that often define medical guidelines—allow physicians consulting for pharmaceutical companies or paid medical writers to extol the virtues of the drugs they are selling.

I hate to ruin the fun, but practicing physicians are influenced far more by guidelines, esteemed academic physicians, and opinion pieces in prestigious journals than we are by a deli platter and a smiling drug rep. We look to the world of academic medicine because, well, where else can we turn? Pharmaceutical companies know this and have worked hard to sway the leadership. Now the question comes up if we can trust the data that the leadership relies on. One wonders how deep the deception goes. In fact, the heavy influence of pharmaceutical dollars inspired the former editor-in-chief of the New England Journal of Medicine, Dr. Marcia Angell, to conclude, “It is simply no longer possible to believe much of the clinical research that is published, or to rely on the judgment of trusted physicians or authoritative medical guidelines.”

That’s why so many practicing physicians and patients alike were relieved that Obamacare would force pharmaceutical companies to come clean about how much money they’re throwing at some doctors.  Sure, it’s fun to ridicule a middle-aged doctor ogling the drug rep’s cleavage while stuffing pens in his pocket or wolfing down a falafel sandwich—but this guy isn’t really the problem and everybody knows it. While $90 million went to drug-company sponsored meals in 2013, according to the Open Payments database, at least $1.4 Billion went to research.  If we can believe that doctors can be bought with a slice of pizza pie, then we cannot underrate the influence of research monies.

And by the way, that $1.4 billion is probably a fraction of what is spent on researchers. Obamacare allows a four-year delay in the reporting of research grants for reasons that really don’t make any sense. An explanation from Medscape does little to satisfy: “The thinking is that if there were public transparency, it might stifle companies from getting involved in very early research…. And that’s again to specifically protect that research space.”

Whether or not the research space needs protecting is a matter of debate. Certainly we have so much research that it’s impossible for a working physician to get through it—some 800,000 articles are published annually. In response, the Cochrane Collaboration was formed in the 1990s to perform systematic reviews of the literature. Dr. Peter Gotzsche, the Director of the Nordic Cochrane Center in Copenhagen, has seen enough over the last two decades to sum up his findings in a book whose title says it all: Deadly Medicines and Organised Crime: How Big Pharma has Corrupted Healthcare.

“Much of what the drug industry does fulfills the criteria for organized crime in US law,” Dr. Gotzsche said in a recent interview. “And they behave in many ways like the mafia does, they corrupt everyone they can corrupt, they have bought every type of person, even including ministers of health in some countries…The drug industry buys the professors first, then chiefs of departments, then other chief physicians and so on, they don’t buy junior doctors.”

Gotzsche isn’t the only one accusing pharmaceutical companies of wrongdoing beyond the marketing malfeasance they’re famous for. In Australia, during the Vioxx class action suit brought against Merck, company emails were released revealing that Merck employees planned to “neutralize” and “discredit” doctors who criticized the drug. “We may need to seek them out and destroy them where they live,” a Merck employee wrote, according to The Australian. Apparently, uncooperative physicians were targeted to lose academic appointments and research funding for telling the truth about the negative side effects they observed. 

Big Pharma Wins When Your're Uniformed ,Unhealthy and Possibly Addicted...Don't Let Big Pharma Win!

CardioBeets

I26 31 Day Supply - Canister

i26's powder form means you can take it as part of your daily routine hassle-free! Just mix one or two scoops into a glass of juice or a smoothie in the morning. i26 Powder is a great way to start your morning out right, and the rest of the day will follow.

Womens Health - Health & Nutrition

Youngevity provides powerful products that restore health and build vitality, in addition to having a powerful business opportunity that transforms lives.

Brain - Wellness Tea (56 g)

Formulated to provide smooth mental alertness, Brain also delivers benefits for focus, concentration, memory and cognitive performance. Brain also supplies well-researched neuroprotective compounds from select herbs and teas. It supports brain and nerv

Information Request Form ↘️

ZRadical™ - 32 fl oz

ZRadical , featuring 50 mg of pure fucoidan, is an advanced biotherapeutic drink. Combining the best of nature and science, this powerful blend is formulated to support immune, cardiovascular, neurological, and joint health.* All in a great-tasting dri

📞  +1 (800) 212-2613

Youngevity Social Hub

Youngevity provides powerful products that restore health and build vitality, in addition to having a powerful business opportunity that transforms lives.